51. Parathyroid imaging with 99Tcm-tetrofosmin
- Author
-
P. Marozzi, G Meduri, and Alessandro Giordano
- Subjects
Adenoma ,Adult ,Male ,medicine.medical_specialty ,endocrine system diseases ,Concordance ,chemistry.chemical_element ,Image subtraction ,Scintigraphy ,Technetium ,Thyroid carcinoma ,Parathyroid Glands ,Organophosphorus Compounds ,medicine ,Humans ,Radiology, Nuclear Medicine and imaging ,False Positive Reactions ,Thyroid Neoplasms ,Radionuclide Imaging ,False Negative Reactions ,Aged ,Sodium Pertechnetate Tc 99m ,Hyperparathyroidism ,medicine.diagnostic_test ,business.industry ,Thyroid ,Thyroid adenoma ,General Medicine ,Organotechnetium Compounds ,Middle Aged ,medicine.disease ,Thallium Radioisotopes ,medicine.anatomical_structure ,Parathyroid Neoplasms ,chemistry ,Female ,Radiology ,business ,Nuclear medicine - Abstract
The aim of this study was to evaluate whether 99Tcm-tetrofosmin is a suitable agent for parathyroid scintigraphy. Ten patients with hyperparathyroidism and two normal subjects underwent parathyroid scintigraphy with both 99Tcm-tetrofosmin and 201TI. Thyroid image subtraction was performed with 99Tcm-pertechnetate. In the 10 patients with hyperparathyroidism, the scintigraphic results were compared with the surgical findings, which showed seven parathyroid adenomas, two parathyroid adenomas with a co-existing thyroid adenoma, and one thyroid carcinoma. Both 99Tcm-tetrofosmin and 201T1 revealed eight true-positive results, one false-negative results and one false-positive result, with concordance in 8 of 10 patients. The image quality with 99Tcm-tetrofosmin of both the raw and 99Tcm-pertechnetate subtracted images was always superior compared with that with 201T1. On the basis of the diagnostic results and the favourable dosimetric characteristics, we conclude that 99Tcm-tetrofosmin is a suitable agent for parathyroid scintigraphy.
- Published
- 1996